Skip Navigation
Skip to contents

Korean J Hematol.  2006 Jun;41(2):129-133. 10.5045/kjh.2006.41.2.129.

CD56+ T-cell Prolymphocytic Leukemia Showing a High Expression Level of TCL1 Oncogene: A Case Report with a Review of the Literature

Affiliations
  • 1Department of Laboratory Medicine, Chonnam National University Medical School, Chonnam National University Hwasun Hospital, Korea. mgshin@chonnam.ac.kr
  • 2Genome Research Center for Hematopoietic Disease, Chonnam National University Hwasun Hospital, Korea.
  • 3Department of Laboratory Medicine, Sunchon St. Carollo Hospital, Hwasun, Korea.

Abstract

T-cell prolymphocytic leukemia (T-PLL) is a rare mature post-thymic T-cell malignancy with infiltration to the blood, bone marrow, lymph node, liver, spleen and skin; this disease has a poor prognosis and an aggressive clinical course. We report here on a case of CD56+ T-PLL that was diagnosed by hematological examination, immunophenotyping and molecular studies including determining the TCL1 expression by using reverse-transcriptase polymerase chain reaction (RT-PCR), and direct sequencing of the RT-PCR product.

Keyword

T-cell Prolymphocytic Leukemia; TCL1; CD56

MeSH Terms

Bone Marrow
Immunophenotyping
Leukemia, Prolymphocytic, T-Cell*
Liver
Lymph Nodes
Oncogenes*
Polymerase Chain Reaction
Prognosis
Skin
Spleen
T-Lymphocytes*
Full Text Links
  • KJH
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2026 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr